Jou‐Wei Lin
Impact in
- Emergency Medicine top 0.2%
- Cardiac Arrest and Resuscitation
- Hepatology top 2%
- Hepatitis C virus research
Papers in
- Hepatology 15
- Hepatitis C virus research 12
-
- Heart Failure Treatment and Management 9
- Co-authors
- Chia‐Hsuin ChangMei‐Shu LaiLee‐Ming ChuangJuey‐Jen HwangYih‐Sharng ChenLi‐Chiu WuWen‐Je KoJames L. Caffrey
- Journals
- PLoS ONE (9 papers)Scientific Reports (7 papers)Atherosclerosis (4 papers)Resuscitation (3 papers)Pharmacoepidemiology and Drug Safety (3 papers)
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Jou‐Wei Lin
152 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Emergency Medicine 1.2k
- Hepatology 476
- Cardiology and Cardiovascular Medicine 828
- Endocrinology, Diabetes and Metabolism 577
- Surgery 1.4k
Countries citing papers authored by Jou‐Wei Lin
This map shows the geographic impact of Jou‐Wei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jou‐Wei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jou‐Wei Lin more than expected).
Fields of papers citing papers by Jou‐Wei Lin
This network shows the impact of papers produced by Jou‐Wei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jou‐Wei Lin. The network helps show where Jou‐Wei Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jou‐Wei Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 13 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 20 | |
| 7 | 2021 | 6 | |
| 8 | 2021 | 34 | |
| 9 | 2021 | 10 | |
| 10 | 2021 | 7 | |
| 11 | 2019 | 7 | |
| 12 | 2019 | 7 | |
| 13 | 2015 | 7 | |
| 14 | 2014 | 18 | |
| 15 | 2013 | 12 | |
| 16 | 2009 | 0 | |
| 17 | Comparing the Process of Quality of Care for Managing Acute ST-Segment Elevation Myocardial Infarction Between Headquarter and Branch Hospitals | 2008 | 2 |
| 18 | Development of a Coronary Artery Aneurysm Following Stent Implantation in a Chronic, Totally Occluded Lesion | 2007 | 1 |
| 19 | Coronary Stent Strut Avulsion and Cutting Balloon Fracture in Treating In-stent Restenosis | 2004 | 3 |
| 20 | 1994 | 73 |
About Jou‐Wei Lin
Jou‐Wei Lin is a scholar working on Hepatology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Emergency Medicine and Nephrology, having authored 157 papers that have together received 5.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (16 papers), Mechanical Circulatory Support Devices (13 papers), Hepatitis C virus research (12 papers), Cardiac Arrest and Resuscitation (12 papers), Diabetes Treatment and Management (11 papers), Cardiac Structural Anomalies and Repair (9 papers), Heart Failure Treatment and Management (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers). The work is most often cited by research in Emergency Medicine (1.2k citations), Hepatology (476 citations), Cardiology and Cardiovascular Medicine (828 citations), Endocrinology, Diabetes and Metabolism (577 citations) and Surgery (1.4k citations). Jou‐Wei Lin has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Chia‐Hsuin Chang, Mei‐Shu Lai, Lee‐Ming Chuang, Juey‐Jen Hwang, Yih‐Sharng Chen, Li‐Chiu Wu, Wen‐Je Ko, James L. Caffrey, Chih‐Hsien Wang and Hsi‐Yu Yu. Their work appears in journals such as PLoS ONE, Scientific Reports, Atherosclerosis, Resuscitation and Pharmacoepidemiology and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.